Mavorixafor(AMD-070)
98%
- Product Code: 108883
CAS:
558447-26-0
| Molecular Weight: | 349.4726 g./mol | Molecular Formula: | C₂₁H₂₇N₅ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
Mavorixafor, also known as AMD-070, is primarily used in the treatment of certain medical conditions related to the immune system. It is a CXCR4 antagonist, which means it works by blocking the CXCR4 receptor, a protein involved in the migration and activation of white blood cells. This mechanism is particularly useful in the management of WHIM syndrome, a rare genetic disorder characterized by warts, hypogammaglobulinemia, infections, and myelokathexis. By inhibiting CXCR4, Mavorixafor helps to mobilize white blood cells from the bone marrow into the bloodstream, improving the patient's immune response and reducing the frequency of infections. Additionally, it is being investigated for its potential role in cancer therapy, as CXCR4 is also implicated in the metastasis of certain types of cancer. By blocking this receptor, Mavorixafor may help to prevent the spread of cancer cells to other parts of the body.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | ฿36,486.00 |
+
-
|
Mavorixafor(AMD-070)
Mavorixafor, also known as AMD-070, is primarily used in the treatment of certain medical conditions related to the immune system. It is a CXCR4 antagonist, which means it works by blocking the CXCR4 receptor, a protein involved in the migration and activation of white blood cells. This mechanism is particularly useful in the management of WHIM syndrome, a rare genetic disorder characterized by warts, hypogammaglobulinemia, infections, and myelokathexis. By inhibiting CXCR4, Mavorixafor helps to mobilize white blood cells from the bone marrow into the bloodstream, improving the patient's immune response and reducing the frequency of infections. Additionally, it is being investigated for its potential role in cancer therapy, as CXCR4 is also implicated in the metastasis of certain types of cancer. By blocking this receptor, Mavorixafor may help to prevent the spread of cancer cells to other parts of the body.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :